Background: The risk of endobronchial ultrasound-guided transbronchial biopsy-related pneumothorax is a major concern and warrants further studies. The aim of our study was to estimate the risk of pneumothorax after this procedure and identify its risk factors.
Introduction
Since its advent, endobronchial ultrasound (EBUS) has been widely used to increase the diagnostic yield of transbronchial biopsy for peripheral lung lesions and has had a favourable safety profile. Although rare, complications do exist and pneumothorax and bleeding are the two most frequently encountered. [1] [2] [3] A recent meta-analysis demonstrated that the pooled rates of pneumothorax and intercostal catheter drainage of pneumothorax across 14 studies were 1.0% and 0.4%, respectively. [4] The patients' risk of developing pneumothorax after EBUS-guided transbronchial lung biopsy (TBB) may be identified using risk factor analysis; however, it has not been systematically investigated, to our knowledge. Thus, the purpose of this study was to evaluate the risk factors for pneumothorax following EBUS-guided TBB in a large population. In particular, potentially modifiable risk factors associated with pneumothorax were sought in the hope of minimizing pneumothorax.
Materials and Methods

Study Subjects
From January 2007 to December 2011, all patients who underwent EBUS-guided TBB for peripheral lung lesions and had a post-procedure chest x-ray at the National Taiwan University Hospital were identified from our bronchoscopy registry and were the study subjects. Peripheral lung lesions were defined as lesions being surrounded by the lung parenchyma without evidence of endobronchial abnormalities. This study was approved by the Research Ethics Committee of the National Taiwan University Hospital and written informed consent was obtained from all patients before conducting the bronchoscopy procedure.
Data Collection
Characteristics of the patients, lesions and procedures were collected to determine the risk factors for the occurrence of pneumothorax. The patient characteristics included the age, sex, presence of emphysematous change in the same lobe where the lesion was located on the CT scan, and history of surgery on the side of the lung where the biopsy was taken. The lesion characteristics were the size, lobar location and CT appearance of the lesion. The procedure characteristics included the number of biopsy specimens and position of the EBUS probe relative to the target lung lesion. All chest x-rays and CT scans were examined by two independent pulmonologists. The lesion size was measured as the largest diameter in the axial plane of the CT scan. The probe position was classified as either within ( Figure 1A ) or adjacent ( Figure 1B ) to the lesion, as previously described. [5] Pneumothorax was defined as the presence of air within the pleural space and was detected by the chest x-ray.
Biopsy Procedures
Bronchoscopy was performed after local anaesthesia with 5 mL of 2% lidocaine sprayed or nebulised into the nasal, pharyngeal and laryngeal mucosa with or without intramuscular administration of meperidine 50 mg. Additionally, one or two aliquots of 1 mL of 2% lidocaine were instilled onto the larynx, carina and bronchial tree throughout the procedure. In 2007, an Olympus BF-1T240 video bronchoscope (Olympus, Tokyo, Japan) with a 2.6-mm working channel and an endoscopic ultrasound system (SSD-550, Aloka, Tokyo, Japan), equipped with a 20-MHz radialtype flexible probe were used. The settings of the ultrasound system were as follows: system gain 38 dB; time gain compensation 37; focal position 2 cm; imaging depth 4 cm. After 2008, an Olympus BF-P260F video bronchoscope (Olympus, Tokyo, Japan) with a 2.0-mm working channel was employed and EBUS was performed using an endoscopic ultrasound system (EU-M30S, Olympus, Tokyo, Japan), equipped with a 20-MHz radial-type flexible probe. The settings of the ultrasound system were as follows: system gain 9 dB; time gain compensation 4; imaging depth 4 cm. During the bronchoscopy, oxygen was delivered to the patient via a nasal cannula and continuous pulse oximetry was routinely used to monitor the patient's blood oxygen saturation. EBUS-guided TBB was performed according to our previously described method. [6] The biopsy was repeated until at least three specimens were obtained.
Statistical Analysis
Data were presented as mean6standard deviation or number (percent) as appropriate. The patients with or without pneumothorax after EBUS-guided TBB were compared. The variables evaluated were classified into patient factors (age, sex, pulmonary emphysema, history of lung surgery), lesion factors (size, location, CT appearance) and procedure factors (number of specimens, probe position, year of the procedure). Categorical variables were compared using the chi-square test or Fisher's exact test and continuous variables were compared using the t test. The variables with a p value of less than 0.2 in the univariate analysis were entered into multivariate logistic regression analysis. A two-sided p value of less than 0.05 indicated statistical significance. The analyses were conducted using SPSS statistical software (SPSS version 15; SPSS; Chicago, IL).
Results
A total of 399 consecutive patients (244 men and 155 women) were included in the study. The mean age was 64613 years (range, 20 to 99 years). The average lesion size was 3.461.5 cm (range, 1.0 to 5.8 cm). Forty-five (11%) patients had emphysematous change in the same lobe of the lung lesion and 6 (1.5%) patients had received pulmonary surgery on the same side as the lesion. Table 1 summarizes the characteristics of the study cohort.
Pneumothorax developed in 13 (3.3%) of the 399 patients. In one (7.7%) case, pneumothorax was completely evacuated with an intercostal catheter and manual aspiration and tube thoracostomy was indicated in 4 cases (31%). The remaining 8 patients required only observation and supplemental oxygen therapy. There was no mortality attributable to the development of pneumothorax.
From the univariate analyses, the factors significantly increasing the risk of pneumothorax were the presence of emphysema in the same lobe (p,0.001), non-solid lung lesion (p = 0.001) and EBUS probe positioned adjacent to the lesion (p = 0.004) ( Table 2 ). The independent risk factors for pneumothorax in increasing order of p values obtained in a multivariate logistic regression model (Table 3) were pulmonary emphysema (OR, 55.09; 95% CI, 9.37-324.03; p,0.001) and probe adjacent to the lesion (OR, 17.01; 95% CI, 2.85-101.64; p = 0.002).
Discussion
The present study is dedicated to examine the risk factors for pneumothorax after EBUS-guided TBB in a large patient population. The pneumothorax rate was 3.3% and the presence of emphysema in the same lobe on the CT scan and position of the probe adjacent to the lung lesion were two recognized risk factors for pneumothorax. To further reduce the risk of pneumothorax, it is suggested that the EBUS probe should be introduced inside the target lesion if technically feasible.
EBUS-guided TBB has proven to be a useful and safe procedure for evaluation of a variety of lung diseases and the common and potentially catastrophic complication is pneumothorax. [1] [2] [3] [4] After EBUS-guided TBB, the incidence of pneumothorax ranges from 0% to 5.1% and chest tube placement is required in approximately half of the total pneumothorax cases. [1] [2] [3] [5] [6] [7] [8] [9] [10] Thus, the incidences of pneumothorax and tube thoracostomy for pneumothorax in our study were comparable to those of the aforementioned studies. Fortunately, no deaths due to pneumothorax were reported in our and prior studies.
Emphysema is pathologically characterized as destruction of alveolar architecture, with irreversible enlargement of airspaces distal to the terminal bronchioles. [11] The CT findings of emphysema are focal low attenuation areas, usually without visible walls. [12] In the present study, we found that if emphysema was detected in the same lobe of the target lesion, the risk of postbiopsy pneumothorax remarkably increased (OR, 55.09; 95% CI, 9.37-324.03). The anatomical derangement of emphysema may weaken the lung structure and predispose lung parenchyma to any kind of insults (i.e., lung biopsy here). Also, the disruption of dilated airspaces and lack of elastic recoil may prevent rapid sealing of the air leak. [13] Thus, it is anticipated that the distribution of emphysema is the most important effect of the disease process on the risk of developing clinically evident pneumothorax after EBUS-guided TBB. Indeed, the increased risk does not preclude such a procedure but helps us to be prepared ourselves and patients for potential pneumothorax.
Placing the EBUS probe within the lung lesion has been proved a significant predictor of higher diagnostic yield during EBUSguided TBB. [2, 5, 6] Our study further identified probe position to be an important determinant of the development of pneumothorax. When the probe was advanced within the lesion on the EBUS image, the risk of pneumothorax was significantly decreased. The safety in terms of pneumothorax comes about because the bronchoscopists take biopsies when the lung lesion is well localized by EBUS. This means that the biopsy forceps will less likely touch the visceral pleura, the way pneumothorax develops. Thus, it is crucial to introduce the probe into the bronchus where it is imaged within the target lesion to increase the diagnostic yield as well as decrease the risk of pneumothorax.
In patients undergoing conventional TBB, the number of biopsy specimens obtained was a significant predictive factor for the development of pneumothorax. [14] However, our study investigating EBUS-guided TBB did not show such a relationship. Further, previous investigators did not find a correlation between the number of specimens retrieved and pneumothorax development in studies of conventional CT-guided and CT fluoroscopyguided lung biopsy. [15] [16] [17] Regarding the lesion size, it correlated strongly with the development of pneumothorax in CT-guided biopsy of the lung but did not influence the risk of pneumothorax in EBUS-guided TBB as shown in this study. [18] As the lesion becomes smaller, it is more difficult for the biopsy needle to hit the lesion during CT-guided lung biopsy, making it more likely for specimens to be retrieved from the periphery of the lung lesion or the lung itself. As a result, pneumothorax may easily develop after such a procedure. On the contrary, we perform TBB after the lung lesion is precisely localized by EBUS and this will ensure that the specimens can be correctly obtained from the lesion. Thus, a small lesion size may not be identified as a risk factor for pneumothorax. Other factors investigated, namely, age, sex, history of prior lung surgery and lesion location and character had no predictive value in our analyses. Also, some of these factors have been proved to be independent risk factors for the development of pneumothorax after other lung biopsy procedures. [15, 19] This indicates that the risk factors for postbiopsy pneumothorax may be different for a variety of diagnostic modalities and reinforces the value of the present study. Another reason is that despite our large sample size, the relatively low number of pneumothoraces may well have masked an effect of one or more of these variables. Our study has some limitations. First, whereas chest CT is superior to the chest x-ray in visualizing pneumothorax, [20] none of the patients in this study had a chest CT scan after the biopsy procedure. As a result, the true incidence of pneumothorax might be underestimated. Second, EBUS-guided TBB was performed by a cooperative team consisting of operators with varying degrees of experience in our institution, even though they were under supervision of more experienced specialist pulmonologists. In this regard, we could not evaluate the effect of operator expertise with the procedure on pneumothorax, yet it has been shown in many studies that the level of experience of the operators does not affect the risks of pneumothorax. [14, 16, 21] Finally, multiple testing for multiple variables, as conducted here, is surely associated with an inflated alpha error. Despite this concern, variables with a high odds ratio may represent true risk factors and attention should be paid to the patients with such variables. In summary, EBUS-guided TBB is a safe diagnostic modality for peripheral lung lesions. Pneumothorax occurred in 3.3% (13/ 399) of procedures after EBUS-guided TBB and all these patients made a good recovery. Pulmonary emphysema and EBUS probe adjacent to the lesion were associated with a higher risk of postprocedure pneumothorax. To reduce the risk of pneumothorax, we suggest that the bronchoscopists introduce the probe into the bronchus, where it is imaged within the lung lesion, as far as possible.
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